Publication date: Aug 11, 2026
Healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) are significant problems, especially in intensive care units (ICUs). We evaluated HAI rates, causative pathogens, resistance profiles, and antibiotic consumption retrospectively in a tertiary ICU across three 2-year periods-pre-pandemic period (PreP), pandemic period (PanP), and post-pandemic period (PostP)-to assess the impact of the COVID-19 pandemic. Antibiotic consumption was expressed as defined daily dose (DDD) per 1,000 patient days. The highest infection incidence rate and density were in PanP. Despite lower invasive device use, PanP had a higher rate of catheter-related bloodstream infections (BSIs). The most frequent pathogen across periods was Acinetobacter spp. , although its rate declined in PostP. Gram-negative bacteria resistance rates to piperacillin-tazobactam, carbapenem, and aminoglycoside were highest in PanP. Resistant pathogen and resistant infection rates were lower in PostP, and resistant infections were less frequent in PostP than in PanP (OR: 0. 371; 95% CI: 0. 216-0. 637; p
| Concepts | Keywords |
|---|---|
| antimicrobial resistance | |
| COVID-19 | |
| healthcare-associated infections | |
| infection control | |
| intensive care unit |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 Pandemic |
| disease | MESH | Infections |
| disease | MESH | DDD |
| disease | MESH | bloodstream infections |
| drug | DRUGBANK | Piperacillin |
| drug | DRUGBANK | Tazobactam |
| disease | MESH | Healthcare-associated pneumonia |